To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A
Clinical trial NCT07548411 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07548411
- Sponsor
- Gritgen Therapeutics Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-10
- Primary completion
- 2024-12-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.